Last reviewed · How we verify

NCT07523841

Non-surgical Periodontitis Treatment With Aspirin and Omega-3

Active, enrolled NA Last updated 15 April 2026
What this trial tests

NA trial testing Scaling and Root Planing (SRP) in Periodontitis in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 April 2023
Primary endpoint
1 April 2027
1 May 2027

Quick facts

Lead sponsorHanoi Medical University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment120
Start date1 April 2023
Primary completion1 April 2027
Estimated completion1 May 2027
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Hanoi Medical University

Who can join

20 Days and older, any sex, with Periodontitis or Periodontitis (Stage 3). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn if non-surgical periodontal treatment combined with Omega-3 fatty acids and Aspirin can improve clinical outcomes and biochemical markers in patients with periodontitis. The main questions it aims to answer are: Does the combination of Omega-3 and low-dose Aspirin significantly change the concentration of biochemical and immunological markers such as Interleukin-6 (IL-6) and C-reactive protein (CRP) in serum? Is the combination of Omega-3 and Aspirin more effective than Omega-3 alone or standard non-surgical treatment in treating periodontitis? Researchers will compare three groups: Control group: Scaling and root planing (SRP) only. Intervention group 1: SRP combined with Omega-3 fatty acids. Intervention group 2: SRP combined with Omega-3 fatty acids and 81mg Aspirin. The comparison aims to see if the combined therapy (Intervention group 2) provides superior anti-inflammatory effects and better clinical healing compared to the other groups. Participants will: Undergo clinical screening and selection based on study criteria. Be randomly assigned to one of the three treatment arms. Receive non-surgical periodontal treatment (scaling and root planing). Take prescribed supplements (Omega-3 or Omega-3 combined with 81mg Aspirin) according to their assigned group. Provide blood samples to measure changes in biochemical markers (IL-6, CRP).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Scaling and Root Planing (SRP)

Trials testing the same drug.

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Hanoi Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07523841.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing